Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain
- 1 July 1997
- journal article
- Published by Elsevier in Health Policy
- Vol. 41 (1) , 61-72
- https://doi.org/10.1016/s0168-8510(97)00013-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Alterations in prescribing by general practitioner fundholders: an observational studyBMJ, 1995
- Current Prescribing in Primary Care in the UKPharmacoEconomics, 1995
- Transferring the costs of expensive treatments from secondary to primary careBMJ, 1995
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- What Price Depression?The British Journal of Psychiatry, 1994
- Pharmacoeconomical with the truthThe Lancet, 1993
- Health Economics in Primary Care in the UKPharmacoEconomics, 1993
- STOP-Hypertension 2: A Prospective Intervention Trial of “Newer” versus “Older” Treatment Alternatives in Old Patients with HypertensionBlood Pressure, 1993
- FHSA medical advisers: friends or foes?BMJ, 1992
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991